Trial intelligence / Profile preview

Ticagrelor Administration Strategy in Unstable Angina

NCT02612116Phase 4Completed

Sponsor
Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz
Start
Sep 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in unstable angina pectoris (UA), sponsored by Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz. Started Sep 2015; status: completed.

02

Drugs

ticagrelor
03

Conditions

unstable angina pectoris (UA)

Beyond the preview

Go deeper on NCT02612116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02612116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call